speb/financial-data huggingface dataset:
PLAB balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 2009224000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Minority Interest: 366460000.00
PLAB income_statement (quarterly, 2025-01-31) — Minority Interests: -15406000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: -4573000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income: 42851000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 42851000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 58257000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 42851000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 42851000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 58257000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 58257000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Interest Income: 6538000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: 41482000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: -15343000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -15343000.00
PLAB income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 6538000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 1433000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net Other Investing Changes: 563000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Net PPE: 749809000.00
PLAB cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -35200000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 1127749000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 19338000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 19338000.00
PLAB income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 79554000.00
PLAB income_statement (quarterly, 2025-01-31) — Normalized Income: 28926535.00
PLAB cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 78466000.00
PLAB income_statement (quarterly, 2025-01-31) — Operating Income: 52177000.00
PLAB income_statement (quarterly, 2025-01-31) — Operating Revenue: 212138000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 63303000.00
PLAB cash_flow (quarterly, 2025-01-31) — Other Cash Adjustment Outside Changein Cash: -2674000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 32613000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: -120325000.00
PLAB income_statement (quarterly, 2025-01-31) — Other Income Expense: 18443000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 14690000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 47798000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Receivables: 39831000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Other Short Term Investments: 0.00
PLAB balance_sheet (quarterly, 2025-01-31) — Payables: 85936000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 160012000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Preferred Stock: 0.00
PLAB income_statement (quarterly, 2025-01-31) — Pretax Income: 77158000.00
PLAB cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: -1995000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
PLAB cash_flow (quarterly, 2025-01-31) — Purchase Of Investment: 0.00
PLAB cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -35200000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Raw Materials: 55725000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Receivables: 188438000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Receivables Adjustments Allowances: -1104000.00
PLAB income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 136603000.00
PLAB income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 20792000.00
PLAB cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -15343000.00
PLAB cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -4573000.00
PLAB income_statement (quarterly, 2025-01-31) — Research And Development: 4257000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 731709000.00
PLAB cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 41482000.00
PLAB income_statement (quarterly, 2025-01-31) — Selling General And Administration: 19101000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Share Issued: 63303000.00
PLAB cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 3334000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 1127749000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 1127749000.00
PLAB income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 4518535.00
PLAB income_statement (quarterly, 2025-01-31) — Tax Provision: 18901000.00
PLAB income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.25
PLAB balance_sheet (quarterly, 2025-01-31) — Total Assets: 1704671000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 1127749000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Debt: 2652000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 1494209000.00
PLAB income_statement (quarterly, 2025-01-31) — Total Expenses: 159961000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 210462000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 783837000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 47819000.00
PLAB income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 52177000.00
PLAB income_statement (quarterly, 2025-01-31) — Total Unusual Items: 18443000.00
PLAB income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: 18443000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Work In Process: 1856000.00
PLAB balance_sheet (quarterly, 2025-01-31) — Working Capital: 758191000.00
PLAB income_statement (quarterly, 2025-04-30) — +Operating Expense: 22189000.00
PLAB income_statement (quarterly, 2025-04-30) — +Total Revenue: 210992000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 89484000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 165411000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -1616788000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 489205000.00
PLAB income_statement (quarterly, 2025-04-30) — Basic Average Shares: 60793000.00
PLAB income_statement (quarterly, 2025-04-30) — Basic EPS: 0.15
PLAB cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 642200000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Buildings And Improvements: 189230000.00
PLAB cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -60549000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 30000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Capital Stock: 587000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 530708000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 558407000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Cash Equivalents: 341978000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Cash Financial: 188730000.00
PLAB cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -74594000.00
PLAB cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -87692000.00
PLAB cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 31453000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -3587000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Inventory: -2161000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -6410000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Payable: -3587000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -3587000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Receivables: -3576000.00
PLAB cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -15734000.00
PLAB cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -3576000.00
PLAB cash_flow (quarterly, 2025-04-30) — Changes In Cash: -130833000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Common Stock: 587000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 1100920000.00
PLAB cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -72109000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Construction In Progress: 122474000.00
PLAB income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 133086000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 77288000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Current Assets: 855806000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 11000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 11000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 166783000.00
PLAB cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 19594000.00
PLAB cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 19594000.00
PLAB income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 60974000.00
PLAB income_statement (quarterly, 2025-04-30) — Diluted EPS: 0.15
PLAB income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 8861000.00
PLAB income_statement (quarterly, 2025-04-30) — EBIT: 29935000.00
PLAB income_statement (quarterly, 2025-04-30) — EBITDA: 49529000.00
PLAB cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: 19505000.00
PLAB cash_flow (quarterly, 2025-04-30) — End Cash Position: 530708000.00
PLAB cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -74594000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Finished Goods: 24000.00
PLAB cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -29096000.00
PLAB income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: -31111000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -87295000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Gross PPE: 2424346000.00
PLAB income_statement (quarterly, 2025-04-30) — Gross Profit: 77906000.00
PLAB income_statement (quarterly, 2025-04-30) — Interest Expense: 4000.00
PLAB income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 4000.00
PLAB income_statement (quarterly, 2025-04-30) — Interest Income: 5329000.00
PLAB income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 5329000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Inventory: 61201000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Invested Capital: 1100920000.00
PLAB cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -87692000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Land And Improvements: 12216000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Leases: 20324000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 19000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 19000.00
PLAB cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -2623000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 2080047000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Minority Interest: 395849000.00
PLAB income_statement (quarterly, 2025-04-30) — Minority Interests: -15356000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -72109000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income: 8861000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 8861000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 24217000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 8861000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 8861000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 24217000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 24217000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Interest Income: 5325000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: -27689000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -2623000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -2623000.00
PLAB income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 5325000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: 150000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net Other Investing Changes: 546000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Net PPE: 807558000.00
PLAB cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -60549000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 1100920000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Assets: 24727000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Assets: 24727000.00
PLAB income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 80640000.00
PLAB income_statement (quarterly, 2025-04-30) — Normalized Income: 34032731.22
PLAB cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 31453000.00
PLAB income_statement (quarterly, 2025-04-30) — Operating Income: 55717000.00
PLAB income_statement (quarterly, 2025-04-30) — Operating Revenue: 210992000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 58711000.00
PLAB cash_flow (quarterly, 2025-04-30) — Other Cash Adjustment Outside Changein Cash: -164000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 40221000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -87295000.00
PLAB income_statement (quarterly, 2025-04-30) — Other Income Expense: -31111000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 14941000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 39461000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Properties: 55000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Receivables: 31737000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 27699000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Payables: 89484000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 166772000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 0.00
PLAB income_statement (quarterly, 2025-04-30) — Pretax Income: 29931000.00
PLAB cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: -12000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
PLAB cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -27689000.00
PLAB cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -60549000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Raw Materials: 59938000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Receivables: 195977000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Receivables Adjustments Allowances: -1171000.00
PLAB income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 133086000.00
PLAB income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 19594000.00
PLAB cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -2623000.00
PLAB cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -72109000.00
PLAB income_statement (quarterly, 2025-04-30) — Research And Development: 4090000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 698423000.00
PLAB cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 0.00
PLAB income_statement (quarterly, 2025-04-30) — Selling General And Administration: 18099000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Share Issued: 58711000.00
PLAB cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 3376000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 1100920000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 1100920000.00
PLAB income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -5939268.78
PLAB income_statement (quarterly, 2025-04-30) — Tax Provision: 5714000.00
PLAB income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.19
PLAB balance_sheet (quarterly, 2025-04-30) — Total Assets: 1703032000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 1100920000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Debt: 30000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 1496769000.00
PLAB income_statement (quarterly, 2025-04-30) — Total Expenses: 155275000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 206263000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 847226000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 39480000.00
PLAB income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 55717000.00
PLAB income_statement (quarterly, 2025-04-30) — Total Unusual Items: -31111000.00
PLAB income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -31111000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Work In Process: 1239000.00
PLAB balance_sheet (quarterly, 2025-04-30) — Working Capital: 689023000.00
PLAB income_statement (quarterly, 2025-07-31) — +Operating Expense: 22694000.00
PLAB income_statement (quarterly, 2025-07-31) — +Total Revenue: 210394000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 100351000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 190875000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -1657948000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 483081000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Allowance For Doubtful Accounts Receivable: -1184000.00
PLAB income_statement (quarterly, 2025-07-31) — Basic Average Shares: 57937000.00
PLAB income_statement (quarterly, 2025-07-31) — Basic EPS: 0.40
PLAB cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 530708000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Buildings And Improvements: 192625000.00
PLAB cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -24839000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 27000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Capital Stock: 576000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 479521000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 575798000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Cash Equivalents: 308375000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Cash Financial: 171146000.00
PLAB cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -20212000.00
PLAB cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -92752000.00
PLAB cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 50055000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Account Payable: -6835000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Inventory: -1400000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: -1075000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Payable: -6835000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: -6835000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Receivables: 8085000.00
PLAB cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -1225000.00
PLAB cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: 8085000.00
PLAB cash_flow (quarterly, 2025-07-31) — Changes In Cash: -62909000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Common Stock: 576000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 1125551000.00
PLAB cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -20740000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Construction In Progress: 108743000.00
PLAB income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 139539000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 74563000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Current Assets: 872236000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 11000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 11000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 174925000.00
PLAB cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 18848000.00
PLAB cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 18848000.00
PLAB income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 58068000.00
PLAB income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.39
PLAB income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 22891000.00
PLAB income_statement (quarterly, 2025-07-31) — EBIT: 38733000.00
PLAB income_statement (quarterly, 2025-07-31) — EBITDA: 57581000.00
PLAB cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: 11826000.00
PLAB cash_flow (quarterly, 2025-07-31) — End Cash Position: 479521000.00
PLAB cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -20212000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Finished Goods: 22000.00
PLAB cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 25216000.00
PLAB income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: -14258000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: -68504000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Gross Accounts Receivable: 192059000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Gross PPE: 2496936000.00
PLAB income_statement (quarterly, 2025-07-31) — Gross Profit: 70855000.00
PLAB income_statement (quarterly, 2025-07-31) — Interest Expense: 0.00
PLAB income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 0.00
PLAB income_statement (quarterly, 2025-07-31) — Interest Income: 4830000.00
PLAB income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 4830000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Inventory: 63490000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Invested Capital: 1125551000.00
PLAB cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -92752000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Land And Improvements: 12298000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Leases: 21037000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 16000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 16000.00
PLAB cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -3000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Machinery Furniture Equipment: 2162233000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Minority Interest: 412449000.00
PLAB income_statement (quarterly, 2025-07-31) — Minority Interests: -6248000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -20740000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income: 22891000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 22891000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 29139000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 22891000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 22891000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 29139000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 29139000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Interest Income: 4830000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: -68216000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: -3000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: -3000.00
PLAB income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 4830000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: 537000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net Other Investing Changes: 303000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Net PPE: 838988000.00
PLAB cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -24839000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 1125551000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 26419000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Assets: 26419000.00
PLAB income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 71839000.00
PLAB income_statement (quarterly, 2025-07-31) — Normalized Income: 33613016.00
PLAB cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 50055000.00
PLAB income_statement (quarterly, 2025-07-31) — Operating Income: 48161000.00
PLAB income_statement (quarterly, 2025-07-31) — Operating Revenue: 210394000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 57587000.00
PLAB cash_flow (quarterly, 2025-07-31) — Other Cash Adjustment Outside Changein Cash: -104000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 42073000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: -68504000.00
PLAB income_statement (quarterly, 2025-07-31) — Other Income Expense: -14258000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 15122000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 39824000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 96277000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Payables: 100351000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 174914000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
PLAB income_statement (quarterly, 2025-07-31) — Pretax Income: 38733000.00
PLAB cash_flow (quarterly, 2025-07-31) — Proceeds From Stock Option Exercised: -6000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Properties: 0.00
PLAB cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -68882000.00
PLAB cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -24839000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Raw Materials: 61908000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Receivables: 190875000.00
PLAB income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 139539000.00
PLAB income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 18848000.00
PLAB cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -3000.00
PLAB cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -20740000.00
PLAB income_statement (quarterly, 2025-07-31) — Research And Development: 4271000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 710398000.00
PLAB cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 666000.00
PLAB income_statement (quarterly, 2025-07-31) — Selling General And Administration: 18423000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Share Issued: 57587000.00
PLAB cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 3293000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 1125551000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 1125551000.00
PLAB income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -3535984.00
PLAB income_statement (quarterly, 2025-07-31) — Tax Provision: 9594000.00
PLAB income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.25
PLAB balance_sheet (quarterly, 2025-07-31) — Total Assets: 1752765000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 1125551000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Debt: 27000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 1538000000.00
PLAB income_statement (quarterly, 2025-07-31) — Total Expenses: 162233000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 214765000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 880529000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 39840000.00
PLAB income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 48161000.00
PLAB income_statement (quarterly, 2025-07-31) — Total Unusual Items: -14258000.00
PLAB income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -14258000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Work In Process: 1560000.00
PLAB balance_sheet (quarterly, 2025-07-31) — Working Capital: 697311000.00
PLAB income_statement (annual, 2025-10-31) — +Operating Expense: 91669000.00
PLAB income_statement (quarterly, 2025-10-31) — +Operating Expense: 23427000.00
PLAB income_statement (annual, 2025-10-31) — +Total Revenue: 849294000.00
PLAB income_statement (quarterly, 2025-10-31) — +Total Revenue: 215770000.00
PLAB balance_sheet (annual, 2025-10-31) — Accounts Payable: 84209000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 84209000.00
PLAB balance_sheet (annual, 2025-10-31) — Accounts Receivable: 195921000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 195921000.00
PLAB balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -1634873000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -1634873000.00
PLAB balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 486934000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 486934000.00
PLAB balance_sheet (annual, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -1166000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -1166000.00
PLAB cash_flow (annual, 2025-10-31) — Amortization Cash Flow: 347000.00
PLAB cash_flow (annual, 2025-10-31) — Amortization Of Intangibles: 347000.00
PLAB income_statement (annual, 2025-10-31) — Basic Average Shares: 59606000.00
PLAB income_statement (quarterly, 2025-10-31) — Basic Average Shares: 57600000.00
PLAB income_statement (annual, 2025-10-31) — Basic EPS: 2.29
PLAB income_statement (quarterly, 2025-10-31) — Basic EPS: 1.07
PLAB cash_flow (annual, 2025-10-31) — Beginning Cash Position: 601243000.00
PLAB cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 479521000.00
PLAB balance_sheet (annual, 2025-10-31) — Buildings And Improvements: 192860000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Buildings And Improvements: 192860000.00
PLAB cash_flow (annual, 2025-10-31) — Capital Expenditure: -188231000.00
PLAB cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -67643000.00
PLAB balance_sheet (annual, 2025-10-31) — Capital Lease Obligations: 5959000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 5959000.00
PLAB balance_sheet (annual, 2025-10-31) — Capital Stock: 576000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Capital Stock: 576000.00
PLAB balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 492256000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 492256000.00
PLAB balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 588165000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 588165000.00
PLAB balance_sheet (annual, 2025-10-31) — Cash Equivalents: 270090000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Cash Equivalents: 270090000.00
PLAB balance_sheet (annual, 2025-10-31) — Cash Financial: 222166000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Cash Financial: 222166000.00
PLAB cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: -115257000.00
PLAB cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 27000.00
PLAB cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Investing Activities: -238899000.00
PLAB cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -65300000.00
PLAB cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: 247798000.00
PLAB cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 87824000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Account Payable: -12913000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Account Payable: 6240000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Inventory: -4942000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Inventory: 1152000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Other Current Assets: -4715000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: 3292000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Payable: -12913000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Payable: 6240000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: -12913000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 6240000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Receivables: 6309000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Receivables: -6069000.00
PLAB cash_flow (annual, 2025-10-31) — Change In Working Capital: -16261000.00
PLAB cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 4615000.00
PLAB cash_flow (annual, 2025-10-31) — Changes In Account Receivables: 6309000.00
PLAB cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -6069000.00
PLAB cash_flow (annual, 2025-10-31) — Changes In Cash: -106358000.00
PLAB cash_flow (quarterly, 2025-10-31) — Changes In Cash: 22551000.00
PLAB balance_sheet (annual, 2025-10-31) — Common Stock: 576000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Common Stock: 576000.00
PLAB balance_sheet (annual, 2025-10-31) — Common Stock Equity: 1173589000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 1173589000.00
PLAB cash_flow (annual, 2025-10-31) — Common Stock Payments: -97422000.00
PLAB cash_flow (quarterly, 2025-10-31) — Common Stock Payments: 0.00
PLAB balance_sheet (annual, 2025-10-31) — Construction In Progress: 134880000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Construction In Progress: 134880000.00
PLAB income_statement (annual, 2025-10-31) — Cost Of Revenue: 549464000.00
PLAB income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 140236000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Accrued Expenses: 19010000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 19010000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Assets: 890052000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Assets: 890052000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Capital Lease Obligation: 1986000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 1986000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Debt And Capital Lease Obligation: 1986000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 1986000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Deferred Liabilities: 9491000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 9491000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Deferred Revenue: 9491000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 9491000.00
PLAB balance_sheet (annual, 2025-10-31) — Current Liabilities: 165873000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 165873000.00
PLAB cash_flow (annual, 2025-10-31) — Deferred Income Tax: -17168000.00
PLAB cash_flow (annual, 2025-10-31) — Deferred Tax: -17168000.00
PLAB cash_flow (annual, 2025-10-31) — Depreciation: 77258000.00
PLAB cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 77605000.00
PLAB cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 18371000.00
PLAB cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 77605000.00
PLAB cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 18371000.00
PLAB income_statement (annual, 2025-10-31) — Diluted Average Shares: 59920000.00
PLAB income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 57977000.00
PLAB income_statement (annual, 2025-10-31) — Diluted EPS: 2.28
PLAB income_statement (quarterly, 2025-10-31) — Diluted EPS: 1.07
PLAB income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 136405000.00
PLAB income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 61801000.00
PLAB income_statement (annual, 2025-10-31) — EBIT: 221839000.00
PLAB income_statement (quarterly, 2025-10-31) — EBIT: 75965000.00
PLAB income_statement (annual, 2025-10-31) — EBITDA: 299444000.00
PLAB income_statement (quarterly, 2025-10-31) — EBITDA: 94336000.00
PLAB cash_flow (annual, 2025-10-31) — Effect Of Exchange Rate Changes: 228000.00
PLAB cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: -9901000.00
PLAB balance_sheet (annual, 2025-10-31) — Employee Benefits: 13218000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Employee Benefits: 13218000.00
PLAB cash_flow (annual, 2025-10-31) — End Cash Position: 492256000.00
PLAB cash_flow (quarterly, 2025-10-31) — End Cash Position: 492256000.00
PLAB cash_flow (annual, 2025-10-31) — Financing Cash Flow: -115257000.00
PLAB cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 27000.00
PLAB balance_sheet (annual, 2025-10-31) — Finished Goods: 1000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Finished Goods: 1000.00
PLAB cash_flow (annual, 2025-10-31) — Free Cash Flow: 59567000.00
PLAB cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 20181000.00
PLAB income_statement (annual, 2025-10-31) — Gain On Sale Of Security: -8310000.00
PLAB income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 18615000.00
PLAB balance_sheet (annual, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -86120000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -86120000.00
PLAB balance_sheet (annual, 2025-10-31) — Gross Accounts Receivable: 197087000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 197087000.00
PLAB balance_sheet (annual, 2025-10-31) — Gross PPE: 2489309000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Gross PPE: 2489309000.00
PLAB income_statement (annual, 2025-10-31) — Gross Profit: 299830000.00
PLAB income_statement (quarterly, 2025-10-31) — Gross Profit: 75534000.00
PLAB balance_sheet (annual, 2025-10-31) — Income Tax Payable: 21094000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 21094000.00
PLAB income_statement (annual, 2025-10-31) — Interest Expense: 55000.00
PLAB income_statement (quarterly, 2025-10-31) — Interest Expense: 3000.00
PLAB income_statement (annual, 2025-10-31) — Interest Expense Non Operating: 55000.00
PLAB income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 3000.00
PLAB income_statement (annual, 2025-10-31) — Interest Income: 21988000.00
PLAB income_statement (quarterly, 2025-10-31) — Interest Income: 5243000.00
PLAB income_statement (annual, 2025-10-31) — Interest Income Non Operating: 21988000.00
PLAB income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 5243000.00
PLAB balance_sheet (annual, 2025-10-31) — Inventory: 61767000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Inventory: 61767000.00
PLAB balance_sheet (annual, 2025-10-31) — Invested Capital: 1173589000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Invested Capital: 1173589000.00
PLAB cash_flow (annual, 2025-10-31) — Investing Cash Flow: -238899000.00
PLAB cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -65300000.00
PLAB balance_sheet (annual, 2025-10-31) — Land And Improvements: 12245000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Land And Improvements: 12245000.00
PLAB balance_sheet (annual, 2025-10-31) — Leases: 20474000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Leases: 20474000.00
PLAB balance_sheet (annual, 2025-10-31) — Long Term Capital Lease Obligation: 3973000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 3973000.00
PLAB balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 3973000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 3973000.00
PLAB cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -17972000.00
PLAB cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -3000.00
PLAB balance_sheet (annual, 2025-10-31) — Machinery Furniture Equipment: 2128850000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 2128850000.00
PLAB balance_sheet (annual, 2025-10-31) — Minority Interest: 423718000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Minority Interest: 423718000.00
PLAB income_statement (annual, 2025-10-31) — Minority Interests: -53829000.00
PLAB income_statement (quarterly, 2025-10-31) — Minority Interests: -16820000.00
PLAB cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: -97422000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
PLAB income_statement (annual, 2025-10-31) — Net Income: 136405000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income: 61801000.00
PLAB income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 136405000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 61801000.00
PLAB income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 190234000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 78621000.00
PLAB income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 136405000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 61801000.00
PLAB income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 136405000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 61801000.00
PLAB cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 190234000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 78621000.00
PLAB income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 190234000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 78621000.00
PLAB cash_flow (annual, 2025-10-31) — Net Intangibles Purchase And Sale: -94000.00
PLAB income_statement (annual, 2025-10-31) — Net Interest Income: 21933000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Interest Income: 5240000.00
PLAB cash_flow (annual, 2025-10-31) — Net Investment Purchase And Sale: -52826000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 1597000.00
PLAB cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -17972000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -3000.00
PLAB cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -17972000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -3000.00
PLAB income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: 21933000.00
PLAB income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 5240000.00
PLAB cash_flow (annual, 2025-10-31) — Net Other Investing Changes: 2158000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: 746000.00
PLAB balance_sheet (annual, 2025-10-31) — Net PPE: 854436000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Net PPE: 854436000.00
PLAB cash_flow (annual, 2025-10-31) — Net PPE Purchase And Sale: -188137000.00
PLAB cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -67549000.00
PLAB balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 1173589000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 1173589000.00
PLAB balance_sheet (annual, 2025-10-31) — Non Current Deferred Assets: 40207000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 40207000.00
PLAB balance_sheet (annual, 2025-10-31) — Non Current Deferred Liabilities: 5041000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 5041000.00
PLAB balance_sheet (annual, 2025-10-31) — Non Current Deferred Revenue: 5041000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 5041000.00
PLAB balance_sheet (annual, 2025-10-31) — Non Current Deferred Taxes Assets: 40207000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 40207000.00
PLAB balance_sheet (annual, 2025-10-31) — Non Current Pension And Other Postretirement Benefit Plans: 13218000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Non Current Pension And Other Postretirement Benefit Plans: 13218000.00
PLAB income_statement (annual, 2025-10-31) — Normalized EBITDA: 307754000.00
PLAB income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 75721000.00
PLAB income_statement (annual, 2025-10-31) — Normalized Income: 143534980.00
PLAB income_statement (quarterly, 2025-10-31) — Normalized Income: 47095150.00
PLAB cash_flow (annual, 2025-10-31) — Operating Cash Flow: 247798000.00
PLAB cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 87824000.00
PLAB income_statement (annual, 2025-10-31) — Operating Income: 208161000.00
PLAB income_statement (quarterly, 2025-10-31) — Operating Income: 52107000.00
PLAB income_statement (annual, 2025-10-31) — Operating Revenue: 849294000.00
PLAB income_statement (quarterly, 2025-10-31) — Operating Revenue: 215770000.00
PLAB balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 57633000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 57633000.00
PLAB cash_flow (annual, 2025-10-31) — Other Cash Adjustment Outside Changein Cash: -2857000.00
PLAB cash_flow (quarterly, 2025-10-31) — Other Cash Adjustment Outside Changein Cash: 85000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Current Assets: 4636000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 4636000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Equity Adjustments: -86120000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -86120000.00
PLAB income_statement (annual, 2025-10-31) — Other Income Expense: -8310000.00
PLAB income_statement (quarterly, 2025-10-31) — Other Income Expense: 18615000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Non Current Assets: 19839000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 19839000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Non Current Liabilities: 14592000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 14592000.00
PLAB income_statement (annual, 2025-10-31) — Other Operating Expenses: 240000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Receivables: 12670000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Receivables: 12670000.00
PLAB balance_sheet (annual, 2025-10-31) — Other Short Term Investments: 95909000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 95909000.00
PLAB balance_sheet (annual, 2025-10-31) — Payables: 109102000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Payables: 109102000.00
PLAB balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 128112000.00
PLAB balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 128112000.00
PLAB balance_sheet (annual, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 26284000.00